The paper is available free online.
Ran D. Anbar, MD, Professor of Pediatrics at SUNY Upstate Medical University, in Syracuse, NY, recommends hypnosis as a treatment option when a child’s respiratory symptoms appear to have a psychological component. In his paper, “Adding Hypnosis to the Therapeutic Toolbox of Pediatric Respiratory Care,” Dr. Anbar points to symptoms such as difficulty taking a breath, a disruptive cough, hyperventilation, noise on inspiration such as a gasp or squeak, and difficulty swallowing despite normal lung function as possible indications for the use of hypnosis to supplement medical therapy. Symptoms that are absent during sleep, can be associated with a particular activity or location, or are linked to or triggered by an emotional response may be particularly responsive to hypnosis.
Published data support the benefit of hypnosis in children with respiratory disorders with a large mind-body component such as vocal cord dysfunction and habit cough. Hypnosis can also help lessen sensations of difficulty breathing and anxiety in other respiratory diseases such as cystic fibrosis and asthma. Hypnosis is also a valuable tool for easing a child’s anxiety and helping patients control their response to discomfort.
Dr. Anbar cautions that hypnosis should not be attempted or considered for use by someone who is not a health care provider and has not received appropriate training in the technique.
“Dr. Anbar has added hypnosis to our therapeutic toolbox. When breathing problems have a large mind-body component, resolution with hypnosis can dramatically reduce the need for expensive testing and medications,” says Harold Farber, MD, MSPH, Editor of Pediatric Asthma, Allergy Immunology, and Associate Professor of Pediatrics, Section of Pulmonology, at Baylor College of Medicine, Houston, TX.
Pediatric Asthma, Allergy & Immunology is a quarterly journal published in print and online. The Journal has expanded its coverage to synthesize the pulmonary, allergy, and immunology communities in the advancement of the respiratory health of children. The Journal provides comprehensive coverage to further the understanding, and optimize the treatment, of some of the most common and costly chronic illnesses in children. It includes original translational, clinical and epidemiologic research; public health, quality improvement, and case control studies; patient education research; and the latest research and standards of care for functional and genetic immune deficiencies and interstitial lung diseases. Tables of content and a free sample issue may be viewed online.
Mary Ann Liebert, Inc. is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Journal of Aerosol Medicine and Pulmonary Drug Delivery and Population Health Management. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 60 journals, books, and newsmagazines is available on our website.